Kinsale Capital Partners
Kinsale Capital Partners, LLC is a private equity and merchant banking firm established in 2010 and headquartered in Chicago, Illinois. The firm specializes in management-led leveraged buyouts, targeted acquisitions, and distressed investment advice, focusing on small and lower middle market companies. Kinsale Capital Partners aims to identify and invest in under-managed firms across various sectors, including business and industrial services, consumer services, niche manufacturing, and healthcare. The firm typically targets companies with revenues between $10 million and $100 million, seeking opportunities for growth, restructuring, or ownership transition. Kinsale Capital Partners collaborates with a proprietary network of co-investors to provide capital, while also offering advisory services to enhance the value of its investments. The firm's geographical focus spans the United States, Eastern China, and select regions in Western Europe and South America.
GeneriCo
Venture Round in 2015
GeneriCo, LLC is a pharmaceutical company that specializes in the development and marketing of generic drugs. Founded in 2013 and headquartered in Saint Louis, Missouri, with additional offices in Bengaluru, Italy, and South Korea, GeneriCo focuses on niche generic pharmaceuticals that are often overlooked by larger competitors. The company targets foundational medicines in key therapeutic areas, including cardiovascular health, pain management, central nervous system disorders, oncology, and aging-related conditions. GeneriCo distinguishes itself through its expertise in complex formulations and embedded drug delivery technologies, addressing market needs that are typically neglected by mid-sized and large generic firms. The company's global reach enables it to serve a diverse customer base.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.